What are the brand names of zolpidem?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Zolpidem Brand Names

Zolpidem is marketed under several brand names, most commonly Ambien, with other formulations including Ambien CR (extended-release), Edluar (sublingual), Zolpimist (oral spray), and Intermezzo (low-dose sublingual). 1

Available Formulations

The FDA-approved brand name products containing zolpidem include:

  • Ambien - Immediate-release tablets (the original and most widely prescribed formulation) 2
  • Ambien CR - Extended-release formulation 1
  • Edluar - Sublingual tablet formulation 1
  • Zolpimist - Oral spray formulation (approved 2008, uses NovaMist spray technology with 5 mg per metered spray) 3
  • Intermezzo - Low-dose sublingual formulation for middle-of-the-night awakenings 1
  • Stilnox - Brand name used internationally (particularly in Europe and other markets) 2, 4
  • Myslee - Another international brand name 2

Clinical Context

Zolpidem is classified as a federally controlled substance (Schedule C-IV) due to abuse and dependence potential 1. It is a non-benzodiazepine benzodiazepine receptor agonist (BzRA) that accounts for approximately 87.5% of all BzRA prescriptions, making it the most widely prescribed hypnotic medication in the United States 5.

The generic formulation is simply labeled as zolpidem tartrate and is widely available 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.